These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

851 related items for PubMed ID: 27490003

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Randomized comparison of femoropopliteal artery drug-eluting balloons and drug-eluting stents (FOREST trial): Study protocol for a randomized controlled trial.
    Jongsma H, van Mierlo-van den Broek P, Imani F, van den Heuvel D, de Vries JPM, Fioole B.
    J Vasc Surg; 2017 Oct; 66(4):1293-1298. PubMed ID: 28826727
    [Abstract] [Full Text] [Related]

  • 23. Major adverse limb events in patients with femoro-popliteal and below-the-knee peripheral arterial disease treated with either sirolimus-coated balloon or standard uncoated balloon angioplasty: a structured protocol summary of the "SirPAD" randomized controlled trial.
    Barco S, Sebastian T, Voci D, Engelberger RP, Grigorean A, Holy E, Leeger C, Münger M, Périard D, Probst E, Spescha R, Held U, Kucher N.
    Trials; 2022 Apr 21; 23(1):334. PubMed ID: 35449070
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Atherectomy for peripheral arterial disease.
    Ambler GK, Radwan R, Hayes PD, Twine CP.
    Cochrane Database Syst Rev; 2014 Mar 17; (3):CD006680. PubMed ID: 24638972
    [Abstract] [Full Text] [Related]

  • 26. Acotec Drug-Coated Balloon Catheter: Randomized, Multicenter, Controlled Clinical Study in Femoropopliteal Arteries: Evidence From the AcoArt I Trial.
    Jia X, Zhang J, Zhuang B, Fu W, Wu D, Wang F, Zhao Y, Guo P, Bi W, Wang S, Guo W.
    JACC Cardiovasc Interv; 2016 Sep 26; 9(18):1941-9. PubMed ID: 27659572
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Drug-eluting balloons for femoropopliteal lesions show better performance in de novo stenosis or occlusion than in restenosis.
    Herten M, Torsello GB, Schönefeld E, Imm B, Osada N, Stahlhoff S.
    J Vasc Surg; 2015 Feb 26; 61(2):394-9. PubMed ID: 25307133
    [Abstract] [Full Text] [Related]

  • 29. Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study.
    Reijnen MMPJ, van Wijck I, Zeller T, Micari A, Veroux P, Keirse K, Lee SW, Li P, Voulgaraki D, Holewijn S.
    J Endovasc Ther; 2019 Jun 26; 26(3):305-315. PubMed ID: 30931726
    [Abstract] [Full Text] [Related]

  • 30. Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial.
    Werk M, Albrecht T, Meyer DR, Ahmed MN, Behne A, Dietz U, Eschenbach G, Hartmann H, Lange C, Schnorr B, Stiepani H, Zoccai GB, Hänninen EL.
    Circ Cardiovasc Interv; 2012 Dec 26; 5(6):831-40. PubMed ID: 23192918
    [Abstract] [Full Text] [Related]

  • 31. Drug-coated Balloon Angioplasty of Femoropopliteal Lesions Maintained Superior Efficacy over Conventional Balloon: 2-year Results of the Randomized EffPac Trial.
    Teichgräber U, Lehmann T, Aschenbach R, Scheinert D, Zeller T, Brechtel K, Blessing E, Lichtenberg M, von Flotow P, Heilmeier B, Sixt S, Brucks S, Erbel C, Beschorner U, Werk M, Riambau V, Wienke A, Klumb CT, Thieme M.
    Radiology; 2020 May 26; 295(2):478-487. PubMed ID: 32125256
    [No Abstract] [Full Text] [Related]

  • 32. Drug-Coated Balloons for Revascularization of Infrapopliteal Arteries: A Meta-Analysis of Randomized Trials.
    Cassese S, Ndrepepa G, Liistro F, Fanelli F, Kufner S, Ott I, Laugwitz KL, Schunkert H, Kastrati A, Fusaro M.
    JACC Cardiovasc Interv; 2016 May 23; 9(10):1072-80. PubMed ID: 27131439
    [Abstract] [Full Text] [Related]

  • 33. Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials.
    Cassese S, Byrne RA, Ott I, Ndrepepa G, Nerad M, Kastrati A, Fusaro M.
    Circ Cardiovasc Interv; 2012 Aug 01; 5(4):582-9. PubMed ID: 22851526
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Infrainguinal angioplasty with drug-eluting stents and balloons.
    Canaud L, Ozdemir BA, Belli AM, Loftus IM, Thompson MM, Hinchliffe RJ.
    J Vasc Surg; 2014 Jun 01; 59(6):1721-36. PubMed ID: 24836771
    [Abstract] [Full Text] [Related]

  • 38. The Randomized Freeway Stent Study: Drug-Eluting Balloons Outperform Standard Balloon Angioplasty for Postdilatation of Nitinol Stents in the SFA and PI Segment.
    Tacke J, Müller-Hülsbeck S, Schröder H, Lammer J, Schürmann K, Gross-Fengels W, Fischbach R, Textor J, Boguth L, Loewe C, Häuser H, Gschwendtner M, Tepe G, von Strandmann RP, Stahnke S, Dambach J, Hausegger K.
    Cardiovasc Intervent Radiol; 2019 Nov 01; 42(11):1513-1521. PubMed ID: 31432220
    [Abstract] [Full Text] [Related]

  • 39. Gene therapy for peripheral arterial disease.
    Forster R, Liew A, Bhattacharya V, Shaw J, Stansby G.
    Cochrane Database Syst Rev; 2018 Oct 31; 10(10):CD012058. PubMed ID: 30380135
    [Abstract] [Full Text] [Related]

  • 40. Comparison of efficacy and safety of drug-eluting versus uncoated balloon angioplasty for femoropopliteal arterial occlusive disease: a meta-analysis.
    Feng H, Chen X, Guo X, Zhang Z, Zhang Z, Liu B, Lian L.
    BMC Cardiovasc Disord; 2020 Aug 31; 20(1):395. PubMed ID: 32867681
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 43.